Biotechnology Company
8%
Gene and cell therapy company that treats diseases and aging at the cellular level... with a potential solution to Alzheimer's Disease, Sarcopenia, Atherosclerosis and some cancers. Human clinical trials are scheduled.
Sign up now to unlock full company profiles and access financials, investor documents, and engage companies.
BioViva offers potential single treatment cures and vaccines for sarcopenia, atherosclerosis, Alzheimer's Disease and cancer and will begin human clinical trials in 2018.
Aging is a complex process that inevitably leads to disease and dysfunction, and this is why we are targeting our therapies at aging... to head disease off at the pass. These are some of our immediate targets to develop gene therapies for, and this will develop as we develop new ways to treat illness and learn more about aging:* Lengthen Telomeres* Reverse Atherosclerosis* Clear Misfolded Proteins* Clear Senescent Cells* Re-strengthen Muscles* Re-boot the immune System* Improve Cell Signaling* Treat Monogenic Disease
Ms. Parrish is a humanitarian, entrepreneur and innovator, is a leading voice for genetic cures. As a strong proponent of progress and education for the advancement of regenerative medicine modalities, she serves as a motivational speaker to the public at large for the life sciences. She is actively involved in international educational media outreach and sits on the board of the International Longevity Alliance (ILA). She is an affiliated member of the Complex Biological Systems Alliance (CBSA), which is a unique platform for mensa based, highly gifted persons who advance scientific discourse and discovery. The mission of the CBSA is to further scientific understanding of biological complexity and the nature and origins of human disease. She is also the Secretary of The American Longevity Alliance (ALA) a 501(c)(3) nonprofit trade association that brings together individuals, companies, and organizations who work in advancing the emerging field of cellular & regenerative medicine.
Dr. Williams is a radiologist with a passion for gene and cellular therapies that can be administered under image guidance. He also has an interest in image guided cancer therapies. He did research for several years with adenoviral vector technology for the treatment of cancer. He has spent the last 5 years involved in research using AAV technology. Dr. Williams obtained his medical degree from Louisiana State University and completed an internship in Internal Medicine followed by a residency in Radiology at The University Of South Alabama. In residency, he was selected for the RSNA Research Fellow award. He is board certified by The American Board of Radiology with additional training in image guided cancer and spine procedures. His research interest is in gene therapy and reprogramming of stem cells. He also has research interest in the use of CT and MRI guidance for minimally invasive procedures related to the spine and treatment of cancer.
Mr. Kekich is a recognized authority on longevity science. In 1999, he founded "Maximum Life Foundation", a 501(c)(3) not-for-profit corporation dedicated to reversing human aging and aging related diseases. Since then, the Foundation, in concert with many of the world’s leading researchers, has developed a scientific roadmap to transform the elderly to biological youth.David first became intrigued with extreme life extension in 1977 after founding the country's largest life insurance master general agency, which raised $3.1 billion of premium income for First Executive Corp. This was where he was widely exposed to the realities and horrors of death from aging.Currently, he also serves as CEO of Age Reversal, Inc. and Board Member Life Extension Buyers’ Club..He was a Board Member of the American Aging Assoc and Alcor Life Extension Foundation Patient Care Trust Fund for many years. He authored “Smart, Strong and Sexy at 100, a how-to book for extreme life extension.
Pres. Biogerontology Research Foundation, a UK-based charity for ageing research. Oxford based scientist with degrees in both biomedical & computer science. His PhD research rejuvenates human skin and identifies accurate aging biomarkers. Rejuvenated 80 year old patient skin cells by transplanting mitochondria from 16 y/o skin cells. Using transcriptomics, proteomics and computational biology, he identified pathways to rejuvenate skin. Screens small molecules to replicate regenerative process. His research resulted in advanced protocol to screen drugs with properties that I.D.'d 12 novel geroprotective drugs.Over past 10 years, Avi headed the Oxford Univ. Scientific Society, world’s oldest student scientific organization. Co-founded Oxford Univ. Synthetic Biology Society and others. Organized >370 talks, chaired 8 conferences and hosted 28 Nobel prize winners. Launched Big Data Science in Medicine Conference series & the Longevity Reporter, premier source of health & longevity news
Founder
Bainbridge Island, WA 98110, US
Users who follow these tips increase their fundraising odds substantially.
No commitment. Start in minutes.
Already a member? Log In